SPP1 facilitated cancer cell chemoresistance by activating the CD44 receptor, and anti-SPP1 and anti-CD44 antibodies improved cancer cell sensitivity to cisplatin in a mouse model55. The gene discussed is SPP1; the disease is cancer.